First introduced to the market in 1999, the diabetes drug Actos was trumpeted by the manufacturer Takeda as a safe alternative to treat the disease. However, as a result of thousands of patients who suffered from Actos side effects such as congestive heart failure, the... Read More

Thousands of plaintiffs have become involved in filing an Actos lawsuit after experiencing some of the serious complications that have been linked to the drug. Actos is a medication intended for the treatment of type II diabetes, but patients who take it for an extended... Read More

Much has been written about the link between Actos and bladder cancer, including a 2011 FDA  warning stating that use of Actos can cause bladder cancer. But several recent studies find that Actos (pioglitazone) carries another serious risk as well: the risk of bone fractures.... Read More

In a new lawsuit, a man who developed bladder cancer from Actos states that he had been taking the diabetes drug for more than six years before the FDA finally issued a public warning that Actos could cause bladder cancer. One month after that FDA... Read More

A new complaint has been added to the growing number of lawsuits that have been consolidated in federal court in the Northern District of Alabama. This consolidation was created in order to allow similar cases to be more streamlined and allegations against Pfizer to be... Read More

Anthony Yario joined Actos litigation on November 13, 2012, after filing his side effects lawsuit against drug maker Takeda Pharmaceuticals, et al. and Eli Lilly and Company. Yario, a Wisconsin resident, filed his lawsuit in the Circuit Court of Cook County, Illinois. His lawsuit claims... Read More

A new Actos lawsuit filed on November 13 alleges that the drug caused the plaintiff's bladder cancer. The suit joins many others that charge that the plaintiffs developed bladder cancer as a result of using Actos. Actos side effects A study of 193,000 diabetes patients... Read More